File: Attachment Lotus Reports 2024 AGM Results Feb 2024.pdf

Suite 1010 1030 West Georgia Street, Vancouver, British Columbia V6E 2Y3

Canadian Securities Exchange: Symbol J

Lotus Reports 2024 AGM Results

Vancouver, British Columbia February 19, 2024 Lotus Ventures Inc. (CSE:J) ("Lotus" or the "Company") reports the results from the Annual General Meeting (the "Meeting") hosted in Vancouver BC, on February 12th, 2024. The participation rate for votes totalled 54.2% of the eligible 115,111,439 shares outstanding. The Directors recommended by Management in the Information Circular were appointed. Dale McClanaghan receiving over 74% of votes cast with the balance abstaining, and each of the others, Carl Correia, Maurice Creagh and Simon Davie receiving approximately 82% of votes cast with the balance abstaining. The number of Directors was set at 4, and the shareholders approved the Company's stock option plan, authorized the Board to appoint an Auditor, and ratified all acts, deeds and things done by the Directors of the Company on its behalf since the last Meeting.

ON BEHALF OF LOTUS VENTURES INC: Lotus Ventures Inc. "Dale McClanaghan" Dale McClanaghan, President and CEO

About Lotus Ventures Inc. Lotus Ventures Inc. is a licensed cannabis producer in Canada. Lotus is the owner & operator of the Lotus Cannabis Co.TM brand which sells its premium flower and pre-rolls across British Columbia and Ontario.

Lotus Ventures Inc. is listed on the Canadian Securities Exchange under the symbol J (CSE:J).

For More Information:

President & CEO Dale McClanaghan dalemcclanaghan@gmail.com (604) 644-9844

Investor Relations investors@lotuscannabis.ca

Forward-Looking Information: This document includes certain statements that are not descriptions of historical facts but are forward-looking statements. Such statements include, among others, those concerning our expected financial performance and strategic and operational plans, our future operating results, our expectations regarding the market for medical and recreational cannabis products, our expectations regarding the continued growth of the medical and recreational cannabis market, as well as all assumptions, expectations, predictions, intentions, or beliefs about future events. Users are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause our actual results to differ materially from those anticipated, expressed or implied in the forward-looking statements. These risks and uncertainties have not been documented or mentioned in this document nor other communications made by the company. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.